The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study
Abstract
Twenty-one consecutive patients with streptococcal toxic shock syndrome (TSS) between December 1994 and April 1995 were treated with a median dose of 2 g of intravenous immunoglobulin (IVIG)/kg (cases) and were compared with 32 patients with streptococcal TSS between 1992 and 1995 who did not receive IVIG therapy (controls). The outcome measure was 30-day survival. Patient plasma was tested for its ability to inhibit T cell activation induced by the infecting strain. The proportion of cases with 30-day survival was higher than that of the controls with 30-day survival (67% vs. 34%, respectively; P = .02). Multivariate analysis revealed that IVIG administration and a lower Acute Physiology and Chronic Health Evaluation II score were associated with survival; the odds ratio for survival associated with IVIG therapy was 8.1 (95% confidence interval, 1.6-45; P = .009). IVIG therapy enhanced the ability of patient plasma to neutralize bacterial mitogenicity and reduced T cell production of interleukin-6 and tumor necrosis factor alpha. IVIG may be an effective adjunctive therapy for streptococcal TSS, possibly because of its ability to neutralize bacterial exotoxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Brown, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Biometrics · doi:10.2307/2532174 · Cited by 8,176
Hastie, T., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013604 · Cited by 3,409
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Chambers, J., Hastie, T., & Pregibon, D. (1990) · Compstat · doi:10.1007/978-3-642-50096-1_48 · Cited by 1,742
Stevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., & Kaplan, E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210101 · Cited by 1,216
Manual of Clinical Microbiology
BALOWS, A., HAUSLER Jr., W. J., HERRMANN, K. L., ISENBERG, H. D., & SHADOMY, H. J. (1991) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46651991000600015 · Cited by 1,131
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Invasive Group A Streptococcal Infections in Ontario, Canada
Davies, H. D., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A. E., & Low, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350803 · Cited by 736
Self-citationStevens, D. L., Gibbons, A. E., Bergstrom, R., & Winn, V. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.23 · Cited by 473
Cited by
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Pathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 878
Necrotizing Soft-Tissue Infections
Stevens, D. L., & Bryant, A. E. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1600673 · Cited by 828
Toxic Shock Syndrome and Bacterial Superantigens: An Update
McCormick, J. K., Yarwood, J. M., & Schlievert, P. M. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.77 · Cited by 785
Update on the use of immunoglobulin in human disease: A review of evidence
Perez, E. E., Orange, J. S., Bonilla, F., Chinen, J., Chinn, I. K., Dorsey, M., El-Gamal, Y., Harville, T. O., Hossny, E., Mazer, B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.023 · Cited by 666
ORANGE, J., HOSSNY, E., WEILER, C., BALLOW, M., BERGER, M., BONILLA, F., BUCKLEY, R., CHINEN, J., ELGAMAL, Y., & MAZER, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.015 · Cited by 653
Necrotizing Fasciitis: Current Concepts and Review of the Literature
Sarani, B., Strong, M., Pascual, J., & Schwab, W. C. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.10.032 · Cited by 594
Darenberg, J., Ihendyane, N., Sjolin, J., Aufwerber, E., Haidl, S., Follin, P., Andersson, J., Norrby-Teglund, A., & The Streptlg Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/376630 · Cited by 573
Self-citationStaphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
Hakkarainen, T. W., Kopari, N. M., Pham, T. N., & Evans, H. L. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2014.06.001 · Cited by 460
Current Concepts in the Management of Necrotizing Fasciitis
Misiakos, E. P., Bagias, G., Patapis, P., Sotiropoulos, D., Kanavidis, P., & Machairas, A. (2014) · Frontiers in Surgery · doi:10.3389/fsurg.2014.00036 · Cited by 454
Gram-positive toxic shock syndromes
Lappin, E., & Ferguson, A. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70066-0 · Cited by 433
Epidemiology of Severe Streptococcus pyogenes Disease in Europe
Lamagni, T. L., Darenberg, J., Luca-Harari, B., Siljander, T., Efstratiou, A., Henriques-Normark, B., Vuopio-Varkila, J., Bouvet, A., Creti, R., Ekelund, K., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00422-08 · Cited by 410
Kotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, M. T., Khurshid, A., Green, K., Peeples, J., Wade, J., Thomson, G., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-800 · Cited by 398
Self-citationVaricella‐Zoster Virus: Atypical Presentations and Unusual Complications
Gnann, Jr. (2002) · The Journal of Infectious Diseases · doi:10.1086/342963 · Cited by 396
Clinical uses of intravenous immunoglobulin
Jolles, S., Sewell, W. A. C., & Misbah, S. A. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02834.x · Cited by 374
Epidemiology of Invasive Group A Streptococcus Disease in the United States, 1995–1999
O’Brien, K. L., Beall, B., Barrett, N. L., Cieslak, P. R., Reingold, A., Farley, M. M., Danila, R., Zell, E. R., Facklam, R., Schwartz, B., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341409 · Cited by 357
Self-citationSuperantigens: microbial agents that corrupt immunity
Llewelyn, M., & Cohen, J. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00222-0 · Cited by 327
Managing skin and soft tissue infections: expert panel recommendations on key decision points
Eron, L. J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg466 · Cited by 319
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Alejandria, M. M., Lansang, M. A. D., Dans, L. F., & Mantaring III, J. B. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090 · Cited by 313
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Alejandria, M. M., Lansang, M. A. D., Dans, L. F., & Mantaring III, J. B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090.pub2 · Cited by 302
Diagnosis and management of necrotising fasciitis: a multiparametric approach
Morgan, M. S. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.01.028 · Cited by 279
Invasive Group A Streptococcal Disease: Epidemiology, Pathogenesis and Management
Steer, A. C., Lamagni, T., Curtis, N., & Carapetis, J. R. (2012) · Drugs · doi:10.2165/11634180-000000000-00000 · Cited by 273
Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action
NEGI, V.-S., ELLURU, S., SIBÉRIL, S., GRAFF-DUBOIS, S., MOUTHON, L., KAZATCHKINE, M. D., LACROIX-DESMAZES, S., BAYRY, J., & KAVERI, S. V. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9088-9 · Cited by 271
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock*
Kreymann, K. G., de Heer, G., Nierhaus, A., & Kluge, S. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000295263.12774.97 · Cited by 258
Carapetis, J. R., Jacoby, P., Carville, K., Ang, S.-J. J., Curtis, N., & Andrews, R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu304 · Cited by 256
Madsen, M. B., Hjortrup, P. B., Hansen, M. B., Lange, T., Norrby-Teglund, A., Hyldegaard, O., & Perner, A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4786-0 · Cited by 128
Self-citation
Metadata
- Authors
- Kaul, R., McGeer, A., Norrby‐Teglund, A., Kotb, M., Schwartz, B., O'Rourke, K., Talbot, J., Low, D. E., & The Canadian Streptococcal Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04
- Volume
- 28
- Issue
- 4
- Pages
- 800-807
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2013760221
- Cited by
- 544
- References
- 29
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.